Table 2: Distribution of participants according to COVID-19 characteristics and information needs.
|
|
Number (n) |
Percentage (%) |
|
Symptoms during active disease* Fatigue Muscle pain Loss of smell Back pain Headache Loss of taste Fever Cough Sore throat Difficulty breathing Weight loss Diarrhea Abdominal pain Other (hearing loss, nose burning sensation, kidney pain, pericarditis, nausea, loss of appetite, memory loss, bone pain, eye pain, oral ulcers, feeling of tightness in the chest, bradycardia, dizziness, joint pain, and palpitation) Vomiting Asymptomatic |
207 191 153 151 149 128 106 105 90 67 48 39 30 20
18 5 |
79.1 73.5 58.8 58 57.3 49.2 40.7 40.4 34.6 25.8 18.5 15 11.5 7.7
6.9 1.9 |
|
Whether the patient received support from someone for care during active disease Yes No |
145 115 |
55.8 44.2 |
|
Whether healthcare teams contacted the patient during active disease Yes No |
221 39 |
85 15 |
|
Information needs during active disease* Post-disease test Disease course Medication use Follow-up No information need Other (fear of transmitting the disease to children) |
128 116 113 57 57 1 |
26.9 24.4 23.8 12 12 0.2 |
|
Total |
260 |
100 |
*More than one response was allowed.